Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Tiny Worms Might Serve as 'Canary in the Coal Mine' for Environmental Toxins
  • USA - English


News provided by

Cloudburst Creative

Jun 07, 2016, 13:45 ET

Share this article

Share toX

Share this article

Share toX


Portland, Ore. (PRWEB) June 07, 2016 -- A Eugene, Ore., startup has developed a new technology that uses tiny, transparent worms called nematodes to quickly test water samples for a broad range of environmental toxins that impact human health. The breakthrough could dramatically speed testing, cut costs and reduce training time required for technicians doing environmental testing.

"What we've developed is a 'canary in the coal mine' that can detect a broad range of environmental toxins by monitoring the heart-like pump in a simple organism."

Post this

Developed by NemaMetrix, Inc. (http://nemametrix.com) with assistance from Oregon BEST (http://oregonbest.org), the technology is a new application of the company's existing ScreenChip technology, which was designed for drug screening and uses microfluidics to extract individual nematodes from a reservoir then monitor electrical signals from the worm to quantitatively measure the effects a drug or chemical has on an animal's overall biology.

"We're applying this same technology to environmental toxins," said Matt Beaudet, CEO of NemaMetrix. "What we've developed is a 'canary in the coal mine' that can detect a broad range of environmental toxins by monitoring the heart-like pump in a simple organism, in this case the nematode worm Caenorhabditis elegans, which has a high degree of genetic and neurophysiological similarity to humans."

This nematode measures one millimeter in length and has only a two-week lifespan. Using the nematodes dramatically reduces the time and costs associated with current testing methods, which often involve small fish, or in longer term studies, mice or rats that live for two years and are expensive to maintain.

Because the nematode is such a simple organism, it reacts to a broad range of toxins, and reacts quickly, giving a rapid indication when a toxin is present, Beaudet said.

"This is especially useful when you're not sure of the exact toxin you're looking for," said Beaudet, referring to situations where toxicity might be suspected, but not specific chemicals. "The nematode quickly indicates if there is something bad in the sample that could be harmful to humans, and more in-depth testing can then be performed."

Beaudet compares the technology to electrocardiogram (ECG) tests on humans that can be used to determine a range of conditions beyond just the health of the heart. Most current environmental toxin testing methods, such as mass spectrometry or petri dish tests, take a very binary, qualitative approach, looking to see whether a specific chemical or toxin is present or not, or if it is lethal or not, Beaudet said.

With the NemaMetrix system, operators can detect even a minor depression in neural activity triggered by a toxin.

"You can only do this with a whole animal and a quantitative platform like ours," Beaudet said. "By analyzing the electrical signals from the nematode we can detect abnormalities that indicate a toxin is present long before the effect is so strong it kills the nematode."

Containing the technology in a small, palm-sized device also makes it easy to deploy so that training time for operators might be reduced from weeks or months to a matter of minutes.

A $250,000 investment in the project through Oregon BEST's Early-Stage Investments program (http://oregonbest.org/what-we-offer/startup-support/early-stage-investments) is enabling the University of Oregon spinout to work with Janis Weeks, a UO professor of biology, to advance the technology through lab testing and customer validation from field tests.

The company has previously received funding from ONAMI and OTRADI and is affiliated with the FertiLab Thinkubator (http://fertilabthinkubator.com) in Eugene and the Oregon Regional Accelerator and Innovation Network (RAIN) (http://oregonrain.org) in the state's southern Willamette Valley.

"We've benefited heavily from Oregon's supportive startup ecosystem and raised more than $1 million by leveraging the state's investor network to build a strong set of partnerships that include not only Oregon BEST, but also Cascade Angels, TiE Oregon, the Portland Seed Fund, and the Oregon State University Venture Fund," Beaudet said. The company also won a Small Business Innovation Research (SBIR) grant from the National Institutes of Health.

These connections have helped the company rapidly launch its product, gain customers, expand laboratory space and grow to a staff to 10 people in two years, he said.

In September, 2014, NemaMetrix and five other companies were recognized by The White House for developing "revolutionary life science platform technologies" that have the potential to completely revolutionize the research enterprise, "catalyzing breakthrough discoveries and making it difficult to imagine life without them."

"NemaMetrix is a great example of a company developing a clean technology right here in Oregon that could have a significant global impact on environmental toxin testing around the world," said Ken Vaughn, Director of Commercialization Programs at Oregon BEST. "The technology could be used to monitor and detect toxins from a wide range of human activities, including agriculture, stormwater runoff, industrial discharges and more."

Oregon BEST offers a wide range of funding and support for cleantech startups in Oregon, and currently has more than 40 start-up companies listed as Oregon BEST Companies (http://oregonbest.org/who-we-serve/cleantech-investors/oregon-best-companies) that are receiving help moving their technologies to the marketplace.

Media Contact: Gregg Kleiner, 541-740-9654
Sources: Ken Vaughn, Oregon BEST, 503-725-9801, ken.vaughn(at)oregonbest.org; Matt Beaudet, NemaMetrix, Inc., 541-510-5216, matt.beaudet(at)nemametrix.com

About Oregon BEST http://oregonbest.org
Oregon BEST funds and assists cleantech startups, bringing together Oregon’s significant R&D strengths to support entrepreneurs in the creation of new products and services. As the nexus for clean technology innovation, Oregon BEST builds capability, convenes collaborations and accelerates solutions to environmental challenges that deliver prosperity in all corners of Oregon. More than 250 Oregon BEST Member Researchers and a network of nine Oregon BEST Labs at four partner universities (Oregon State University, Oregon Tech, Portland State University, and University of Oregon) offer research expertise and lab equipment to industry. Oregon BEST competitively awards Early-Stage Investments to collaborations between startup companies and Oregon BEST Member Faculty at partner universities.

About NemaMetrix http://nemametrix.com
NemaMetrix is a biotechnology company that developed the ScreenChip, a first-in-class phenomics platform for drug discovery and development utilizing the nematode worm, C. elegans, as a model organism. The company’s mission is to offer an affordable and quicker system than the traditional mouse-model. The ScreenChip system can enable screening of therapeutics for orphan and world diseases. NemaMetrix was founded in 2011 in Eugene, Oregon.

Gregg Kleiner, Cloudburst Creative, +1 (541) 740-9654, [email protected]

Modal title

Tiny, transparent nematodes have a high degree of genetic and neurophysiological similarity to humans.
Tiny, transparent nematodes have a high degree of genetic and neurophysiological similarity to humans.
Tiny, transparent nematodes have a high degree of genetic and neurophysiological similarity to humans.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.